Xeris Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company based in Chicago, Illinois, focused on the development and commercialization of ready-to-use injectable and infusible drug formulations. Leveraging its proprietary formulation technology, Xeris aims to improve patient outcomes by enhancing the delivery and efficacy of therapies in critical areas such as diabetes and oncology. With a strong pipeline and a commitment to addressing unmet medical needs, Xeris is well-positioned to capture growth opportunities within the evolving healthcare landscape, making it an attractive investment for those seeking exposure to the pharmaceutical sector.
Click "Analyze" to generate stock analysis
XERS Price Trend and Signals
XERS Option Volumes & Open Interests (aggregated)
XERS Put Call Ratios and IV (aggregated)
XERS Financials
2025-12-19Somewhat Bullishprice_signal
Monthly high detected.
2025-12-08Bullishmacd_signal
Golden cross below zero detected.
2025-12-02Somewhat Bearishprice_signal
Quarterly low detected.
2025-11-21Somewhat Bearishprice_signal
Quarterly low detected.
2025-11-20Somewhat Bearishprice_signal
Quarterly low detected.
2025-11-18Somewhat Bearishprice_signal
Quarterly low detected.
2025-11-14Somewhat Bearishprice_signal
Quarterly low detected.
2025-11-13Somewhat Bearishprice_signal
Quarterly low detected.
2025-11-07Somewhat Bearishprice_signal
Monthly low detected.
2025-11-06Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-11-06Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-11-06Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-11-06Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-11-06Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.